BioSpace takes a look at some of the stories from the first day of the Alzheimer’s Association International Conference 2021 (AAIC).
DaVita and the dialysis provider’s former CEO Kent Thiry were indicted by a federal grand jury in Denver on charges they conspired with competitors not to hire each other’s key employees, the U.S. Justice Department said on July 15.
U.S. deaths from Covid-19 for the week ended May 16 fell to their lowest in nearly 14 months and the number of new cases continued to decline for a fifth week in a row, according to a Reuters analysis of state and county data.
New cases of Covid-19 in the United States fell for a third week in a row, dropping 15 percent during the week ended May 2 to 347,000 – the lowest weekly total since October – according to a Reuters analysis of state and county data.
New cases of Covid-19 in the United States fell for a fourth week in a row – dropping 17 percent in the week ended May 9 to just under 290,000 – the lowest weekly total since September, according to a Reuters analysis of state and county data.
Novartis is closing a manufacturing facility in Longmont, Colorado acquired by company subsidiary AveXis during 2019 that has provided additional production capacity for Zolgensma, a gene therapy treatment for spinal muscular atrophy.
A potent coronavirus variant originating in South Africa and found to be partly resistant to current vaccines and antibody treatments was detected for the first time in the United States in two South Carolina patients, health officials said.
The first known U.S. case of a highly infectious coronavirus variant discovered in Britain was detected in Colorado on Dec. 29 as President-elect Joe Biden warned it could take years for most Americans to be vaccinated against Covid-19 at current distribution rates.
Companies and industry groups lobbying to get their U.S. workers to the front of the line for COVID vaccination are running into a patchwork of state plans and confusion over who is essential, and who is not.
A new wave of mobile apps that help track exposure to the coronavirus is coming to U.S. states ahead of the holidays as public health officials bet that recently introduced features from Apple Inc. and Alphabet Inc.’s Google will significantly boost adoption and impact.